Loading...

Abbvie Inc (NYSE:ABBV)

152.21 USD +3.1 USD ( +2.08% )
Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist

Wall Street
Price Targets

ABBV Price Targets
Price Targets made by Wall Street

12-month price targets for ABBV stock made by Wall Street professionals. The average price target is 168.02 USD with a low forecast of 116.15 USD and a high forecast of 210 USD.

Lowest
Price Target
116.15 USD
24% Downside
Average
Price Target
168.02 USD
10% Upside
Highest
Price Target
210 USD
38% Upside

12-month price targets for ABBV stock made by Wall Street professionals. The average price target is 168.02 USD with a low forecast of 116.15 USD and a high forecast of 210 USD.

Abbvie Inc Competitors:
Price Targets
EBS
Emergent BioSolutions Inc
36% Upside
BIOVF
Swedish Orphan Biovitrum AB (publ)
21% Upside
MBX
Microbix Biosystems Inc
183% Upside
9995
RemeGen Co Ltd
188% Upside
FGEN
FibroGen Inc
63% Upside
IMNM
Immunome Inc
407% Upside
PAB
Patrys Ltd
471% Upside
KNTE
Kinnate Biopharma Inc
326% Upside

Revenue
Forecast

ABBV Revenue Forecast
Wall Street Forecast

Abbvie Inc's Revenue forecast for three years ahead made by Wall Street analysts. Revenue is forecast to grow at a rate of 1% per year.

Year Avg Range
2024
By 22 analysts
58.1B USD
+1%
53.1B - 61.9B USD
2023
By 26 analysts
57.5B USD
-6%
52.8B - 63B USD
2022
By 26 analysts
61.4B USD
+9%
57.8B - 64.8B USD
CAGR:
Forecast
1%

Operating Income
Forecast

ABBV Operating Income Forecast
Wall Street Forecast

Abbvie Inc's Operating Income forecast for three years ahead made by Wall Street analysts. Operating Income is forecast to grow at a rate of 12% per year.

Year Avg Range
2024
By 23 analysts
27.7B USD
+1%
24.9B - 30.6B USD
2023
By 25 analysts
27.5B USD
-13%
17.4B - 33B USD
2022
By 25 analysts
31.5B USD
+62%
27.7B - 33.2B USD
CAGR:
Forecast
12%

Net Income
Forecast

ABBV Net Income Forecast
Wall Street Forecast

Abbvie Inc's Net Income forecast for three years ahead made by Wall Street analysts. Net Income is forecast to grow at a rate of 25% per year.

Year Avg Range
2024
By 22 analysts
22.3B USD
+1%
19.7B - 24.8B USD
2023
By 27 analysts
22.1B USD
-13%
19.4B - 25.4B USD
2022
By 27 analysts
25.4B USD
+120%
23.9B - 26.6B USD
CAGR:
Forecast
25%

See Also

Other Stocks